IBDEI1EW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22585,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,22586,0)
 ;;=Z91.14^^102^1142^62
 ;;^UTILITY(U,$J,358.3,22586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22586,1,3,0)
 ;;=3^Hx of Past Medication Noncompliance
 ;;^UTILITY(U,$J,358.3,22586,1,4,0)
 ;;=4^Z91.14
 ;;^UTILITY(U,$J,358.3,22586,2)
 ;;=^5063616
 ;;^UTILITY(U,$J,358.3,22587,0)
 ;;=E78.5^^102^1142^63
 ;;^UTILITY(U,$J,358.3,22587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22587,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,22587,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,22587,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,22588,0)
 ;;=I10.^^102^1142^64
 ;;^UTILITY(U,$J,358.3,22588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22588,1,3,0)
 ;;=3^Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,22588,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,22588,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,22589,0)
 ;;=E29.1^^102^1142^94
 ;;^UTILITY(U,$J,358.3,22589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22589,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,22589,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,22589,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,22590,0)
 ;;=C46.7^^102^1142^65
 ;;^UTILITY(U,$J,358.3,22590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22590,1,3,0)
 ;;=3^Kaposi's Sarcoma NEC
 ;;^UTILITY(U,$J,358.3,22590,1,4,0)
 ;;=4^C46.7
 ;;^UTILITY(U,$J,358.3,22590,2)
 ;;=^5133326
 ;;^UTILITY(U,$J,358.3,22591,0)
 ;;=C46.0^^102^1142^66
 ;;^UTILITY(U,$J,358.3,22591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22591,1,3,0)
 ;;=3^Kaposi's Sarcoma,Skin
 ;;^UTILITY(U,$J,358.3,22591,1,4,0)
 ;;=4^C46.0
 ;;^UTILITY(U,$J,358.3,22591,2)
 ;;=^5001100
 ;;^UTILITY(U,$J,358.3,22592,0)
 ;;=K13.3^^102^1142^67
 ;;^UTILITY(U,$J,358.3,22592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22592,1,3,0)
 ;;=3^Leukoplakia,Oral Hairy
 ;;^UTILITY(U,$J,358.3,22592,1,4,0)
 ;;=4^K13.3
 ;;^UTILITY(U,$J,358.3,22592,2)
 ;;=^5008493
 ;;^UTILITY(U,$J,358.3,22593,0)
 ;;=R53.81^^102^1142^69
 ;;^UTILITY(U,$J,358.3,22593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22593,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,22593,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,22593,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,22594,0)
 ;;=A31.0^^102^1142^70
 ;;^UTILITY(U,$J,358.3,22594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22594,1,3,0)
 ;;=3^Mycobacteria,Atypical,Pulmonary
 ;;^UTILITY(U,$J,358.3,22594,1,4,0)
 ;;=4^A31.0
 ;;^UTILITY(U,$J,358.3,22594,2)
 ;;=^5000149
 ;;^UTILITY(U,$J,358.3,22595,0)
 ;;=A31.8^^102^1142^71
 ;;^UTILITY(U,$J,358.3,22595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22595,1,3,0)
 ;;=3^Mycobacterium,Non-Tuberculosis NEC
 ;;^UTILITY(U,$J,358.3,22595,1,4,0)
 ;;=4^A31.8
 ;;^UTILITY(U,$J,358.3,22595,2)
 ;;=^5000152
 ;;^UTILITY(U,$J,358.3,22596,0)
 ;;=A15.9^^102^1142^72
 ;;^UTILITY(U,$J,358.3,22596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22596,1,3,0)
 ;;=3^Mycobacterium,Tuberculosis Active Disease
 ;;^UTILITY(U,$J,358.3,22596,1,4,0)
 ;;=4^A15.9
 ;;^UTILITY(U,$J,358.3,22596,2)
 ;;=^5000066
 ;;^UTILITY(U,$J,358.3,22597,0)
 ;;=R11.2^^102^1142^73
 ;;^UTILITY(U,$J,358.3,22597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22597,1,3,0)
 ;;=3^Nausea/Vomiting
 ;;^UTILITY(U,$J,358.3,22597,1,4,0)
 ;;=4^R11.2
 ;;^UTILITY(U,$J,358.3,22597,2)
 ;;=^5019237
 ;;^UTILITY(U,$J,358.3,22598,0)
 ;;=D70.3^^102^1142^75
 ;;^UTILITY(U,$J,358.3,22598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22598,1,3,0)
 ;;=3^Neutropenia d/t Infection
